Association between serum levels of soluble CD40/CD40 ligand and organ damage in hypertensive patients
Authors:
- 27 July 2010
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 37 (8) , 848-851
Abstract
1. CD40 and CD40 ligand (CD40L) have a critical role in the pathophysiology and risk prediction of coronary artery syndrome, including atherothrombosis and atherosclerosis. However, the contribution of the CD40/CD40L dyad, especially the soluble form of CD40L (sCD40L), to the pathophysiology of hypertension and associated organ damage remains unknown. 2. In the present study, serum levels of CD40 and sCD40L were measured in 328 hypertensive patients with varying degrees of organ damage. The data revealed that serum levels of CD40 were significantly greater in patients with severe, but not mild, organ damage compared with patients without any organ damage. There were no significant differences in serum concentrations of sCD40L between patients with no, mild and severe organ damage. Concentrations of soluble CD40 were comparable in patients with mild organ damage that included left ventricular hypertrophy, retinal damage, renal dysfunction and proteinuria. In contrast, concentrations of soluble CD40 were increased significantly in patients with certain forms of severe organ damage, specifically stroke, but not coronary and peripheral artery disease. 3. Collectively, our data indicate that upregulation of the CD40 system in hypertensive patients with certain forms of severe end-organ damage may contribute to the pro-inflammatory, pro-atherogenic and prothrombotic milieu in hypertension.Keywords
This publication has 20 references indexed in Scilit:
- Preoperative sCD40L Levels Predict Risk of Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft SurgeryCirculation, 2009
- Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic PatientsCirculation, 2003
- Upregulation of CD40-CD40 Ligand (CD154) in Patients With Acute Cerebral IschemiaStroke, 2003
- Participation of protease‐activated receptor‐1 in thrombin‐induced microglial activationJournal of Neurochemistry, 2002
- Differential immune responses to α-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantationJournal of Clinical Investigation, 2000
- Immunologic tolerance for immune system–mediated diseasesJournal of Allergy and Clinical Immunology, 1999
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- Functions of CD40 and Its Ligand, gp39 (CD40L)Critical Reviews in Immunology, 1996
- Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertensionJournal Of Hypertension, 1993
- The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leadsAmerican Heart Journal, 1949